Daily as of 3 Nov 16:00 ET
- Price
- below both $7.25 vs 50 $14.28 / 200 $15.95
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 22 Oct 2026 · projected 29 bars out
AVTX | Avalo TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$7.25
-$0.07 (-0.96%)
Avalo Therapeutics (AVTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $7.17 vs 50 $16.18 / 200 $108.48
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- below both $7.16 vs 50 $11.17 / 200 $16.40
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 28 Sep 2026 · projected 11 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 22 Oct 2026 | 💀Death steep | daily | 29 bars out | Not tested |
| 28 Sep 2026 | 💀Death | 4-hour | 11 bars out | Not tested |
| 7 Jul 2026 | 🟨Golden | 4-hour | 22 bars out | Not tested |
| 24 Jun 2026 | 🟨Golden flat | daily | 3 bars out | Not tested |
| 17 Jun 2026 | 💀Death | 4-hour | 23 bars out | 4 bar cross test |
About AVTX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall